8-K: Longduoduo Co Ltd Restructures Business Operations Through Equity Transfer
Current Report
Longduoduo Co Ltd announces the transfer of its equity interest in Longduoduo Health Technology Co., Ltd. to Beijing Julong Health Consulting Co., Limited, restructuring its business operations.
Summary
- Longduoduo Co Ltd announced on April 2, 2025, that its subsidiary, Longduoduo Company Limited (Hong Kong), entered into an Equity Transfer Agreement with Beijing Julong Health Consulting Co., Limited.
- The agreement transfers the equity interest in Longduoduo Health Technology Co., Ltd. (HTC) from the Hong Kong subsidiary to Beijing Julong Health Consulting Co., Limited.
- Prior to January 2025, HTC and its four subsidiaries conducted all of the business operations of Longduoduo and its subsidiaries.
- Following the transfer, the business operations are now carried out by seven limited companies in China, all subsidiaries of LDDJK Hong Kong Limited, which is a subsidiary of LDD Technology Limited, which is a subsidiary of Longduoduo Company Limited.
- The equity transfer involves 100% of the equity in Longduoduo Health Technology Co., Ltd., valued at RMB 99.99 million.
- The agreed price for the equity transfer is RMB 4 million.
Sentiment
Score: 5
Explanation: The document describes a restructuring event. The sentiment is neutral as it is a strategic decision with potential positive or negative outcomes depending on execution.
Industry Context
Restructuring of business operations is a common strategy for companies to optimize their structure, improve efficiency, and focus on core competencies. This move could be aimed at streamlining Longduoduo's operations in the Chinese market.
Stakeholder Impact
- Shareholders may be impacted by the restructuring, depending on how it affects the company's future performance.
- Employees of Longduoduo Health Technology Co., Ltd. may experience changes as a result of the transfer.
- Customers may see changes in the services or products offered by the restructured entities.
Key Dates
| Date | Description |
|---|---|
| January 2025 | Prior to this date, HTC and its four subsidiaries carried on all of the business operations of the Registrant and its subsidiaries. |
| April 2, 2025 | Date of the Equity Transfer Agreement between Longduoduo Company Limited (Hong Kong) and Beijing Julong Health Consulting Co., Limited. |
| April 2, 2025 | Formally transferred on April 2, 2025. From the date of transfer, the transferor shall no longer enjoy the rights and obligations of a contributor to the transferred capital, and the transferee shall enjoy the rights and obligations of a contributor within the enterprise based on its capital contribution. |
| April 11, 2025 | Date of signature of the report by Zhou Hongxiao, CEO of Longduoduo Company Limited. |
Keywords
Equity Transfer, Business Restructuring, Subsidiary, Longduoduo, Health Technology, China
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.